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Case Report:  
A 33-year-old G6P3023 was found to have a 4.2 cm right adrenal incidentaloma 
during an admission for right pyelonephritis. Computed tomography (CT) was performed 
to rule out perinephric abscess in the setting of worsening leukocytosis while on 
antibiotics (Figure 1). Initial differential diagnosis from endocrinology included 
pheochromocytoma and primary aldosteronism. Due to the lack of typical physical exam 
stigmata, Cushing syndrome was initially of low concern.  Of note, her past medical 
history included hypertension treated with amlodipine 10 mg and hydrochlorothiazide 
12.5 mg. During admission, extensive endocrine laboratory workup demonstrated an 
elevated aldosterone:plasma renin activity (PRA), suppressed dehydroepiandrosterone 
(DHEA), normal 24 hour urine metanephrine and catecholamine, and hypokalemia 
(Table 1).  This initial biochemical workup did not provide any definitive diagnosis; 
however, it did convincingly rule out pheochromocytoma due to the normal 
catecholamine levels in the serum and urine. Eliminating this pathology was critical due 
to the mortality of hypertensive crisis in the perioperative period. 
After discharge from the hospital, the patient was lost to endocrine and surgical 
follow-up, so no further endocrine diagnostic workup was performed during that time. 
Approximately 2 months after discharge, the patient was found to be pregnant and 
established care with maternal-fetal medicine, endocrinology and urology.  Her 
obstetrical course was complicated by worsening hypertension (130/100 at 8 weeks 
gestation), requiring the addition of labetalol 100 mg BID. Despite this, she had 
worsening hypertension (160/100 and 147/97 at 14 and 17 weeks, respectively), so her 





medicine and endocrinology, surgical resection was recommended in the second 
trimester due to maternal-fetal complications associated with adrenal adenomas in 
pregnancy. In addition, current guidelines recommend resection for adenomas greater 
than 4 cm due to concern for adrenocortical carcinoma.1 Preoperative workup included 
magnetic resonance imaging without contrast, demonstrating an unchanged mass, and 
repeat endocrine lab studies. Preoperative lab testing was helpful as aldosterone was 
found to be within normal limits, thereby making primary aldosteronism less likely. 
Additionally, the patient had a suppressed ACTH of <9 pg/mL (normal range: 9-46 
pg/mL) at 15 weeks gestation and on repeat testing at 17 weeks. This result, paired with 
the initial low DHEA finding, led to the diagnosis of subclinical Cushing syndrome. 
Pregnancy induced alterations in diagnostic hormonal labs, such as dexamethasone 
suppression test and urine free cortisol, made definitive diagnosis of subclinical Cushing 
syndrome more difficult. However, the suppressed ACTH on repeat testing, which is 
typically normal to high in pregnancy, strongly suggested a functional adrenocortical 
adenoma.2  Based on the size of the mass, functionality and associated risk of 
hypertension on the pregnancy, adrenalectomy was the best option, per maternal-fetal 
medicine and endocrinology.  
At 19 weeks gestation, the patient underwent an uncomplicated right robotic 
adrenalectomy with the da VinciTM Si (Figure 2), with minimal adjustment in surgical 
technique under general anesthesia. A Veress needle was used for abdominal access 
and establishing pneumoperitoneum. Port placement was mildly cephalad to account for 





and a 30-degree camera was inserted to survey the abdomen. There was no evidence 
of adhesive disease. Under direct visualization, an 8 mm working port was placed just 
under the costal margin at the midclavicular line. Two additional 8 mm robotic ports 
were placed, a standard port caudal on the midclavicular line and finally a long port just 
off the anterior superior iliac spine for the fourth arm. A 12 mm assistant port and 5 mm 
liver retractor port were placed in the midline above the umbilicus. A maximum 
pneumoperitoneum of 12mmHg was maintained throughout the procedure.  She was 
pre-treated with 2 mg dexamethasone for perioperative steroid coverage. The surgical 
duration was 118 minutes with an estimated blood loss of 50 cc.  A pre- and post-op 
fetal ultrasound were done showing appropriate fetal heart rates. Post-operatively, she 
received an additional 2 mg dexamethasone. A cosyntropin stimulation test to evaluate 
the hypothalamic-pituitary axis was completed on the first postoperative day (POD) and 
found to be low, consistent with functional cortisol producing adenoma and subclinical 
Cushing syndrome. Patient was discharged home POD 1 on 5 mg prednisone daily for 
8 weeks for replacement steroids. Pathology report showed adrenocortical neoplasm, 
consistent with adrenocortical adenoma with negative surgical margins (Figure 3). Her 
blood pressure normalized 4 weeks postoperatively and she was taken off all 
antihypertensive medications.  
Due to compliance issues, the patient stopped the steroids three weeks 
postoperatively and denied any symptoms, such as orthostatic signs, dizziness, or 
palpitations. At 36 weeks gestation, cortisol and ACTH were abnormal, prompting 





delivery. Pregnancy progressed with no complications with an estimated fetal weight 
2211 grams (37%) at 33 weeks. At 39 weeks, the patient delivered a healthy 2800 g 
female via cesarean section due to fetal intolerance and failure to progress in the 
second stage of labor. On postpartum day 3, she developed preeclampsia with severe 
range blood pressures up to 182/120.  The patient denied any symptoms, including 
headache, chest pain, shortness of breath, vision changes and epigastric pain. She 
declined magnesium sulfate for seizure prophylaxis. The patient was given labetalol 20 
mg IV and started on labetalol 200 mg BID which was up titrated to 300 mg BID.  
Patient was discharged on labetalol 300 mg TID, amlodipine 10 mg daily, and 5 mg 
prednisone daily for one month of steroid coverage.  
 
 
Discussion: Presented by Huda B. Al-Kouatly, M.D. 
As modern imaging continues to advance, adrenal incidentalomas are more 
frequently diagnosed, posing challenges to providers regarding management.3 The 
majority of these lesions (80%) are benign.3 Herein, we present a case of a large 
adrenal incidentaloma identified in a patient found to be pregnant during surgical 
evaluation.  
The workup for adrenal incidentaloma entails identifying malignant potential or 
functional status using clinical, laboratory, and radiographic testing. The differential 
diagnosis includes adrenocortical carcinoma, pheochromocytoma, primary 
aldosteronism, Cushing syndrome, and benign adenoma.  In this case, none of these 





ACTH led endocrinology to diagnose subclinical Cushing syndrome. This pathology is 
defined as hypercortisolemia without the apparent physical manifestations of typical 
Cushing syndrome.4 It usually presents as unilateral adrenal incidentalomas, as seen in 
our case. Current recommendations on treatment remain controversial, but lean 
towards surgery.4 Interestingly, hypercortisolemia can cause amenorrhea and 
oligomenorrhea leading to infertility, features evidently absent in our patient’s case.5  
Literature reports that untreated Cushing syndrome in pregnancy can lead to 
maternal hypertension, preeclampsia, impaired glucose control, and increased rates of 
premature birth, intrauterine growth restriction, spontaneous abortion, and stillbirth.6 Our 
patient experienced asymptomatic postpartum preeclampsia. In addition to her treated 
subclinical Cushing syndrome, she had additional risk factors of chronic hypertension, 
obesity, and African-American race. 
Diagnosis of the functional status of adrenalomas is complicated by physiologic 
hormonal changes of pregnancy. The hypothalamic-pituitary axis is altered, resulting in 
increased cortisol, aldosterone, and renin levels.7 However, catecholamine levels are 
unchanged, so diagnosis of pheochromocytoma remains analogous to non-pregnant 
patients.6 In contrast, the workup for Cushing syndrome is adjusted.  The 
dexamethasone suppression test is a common initial workup for Cushing syndrome in 
non-pregnant patients. However, its utility in pregnancy is limited as ~40% of pregnant 
patients have abnormal dexamethasone suppression.6 This leads to increased Type I 
Error, with literature endorsing false positive dexamethasone suppression tests in >80% 





is elevated at most to three times the upper limit of normal in pregnancy after the first 
trimester.8 Therefore, it can be helpful if levels are >3 times the upper limit of normal.  
Robotic adrenalectomy is considered equivalent to laparoscopic adrenalectomy, 
which is arguably the standard of care.  Initially it was believed that laparoscopy was  
contraindicated in pregnancy, as the implications of the pneumoperitoneum on the 
mother and developing fetus were of concern.9,10 Specifically, the carbon dioxide 
exposure to the fetus and the increased intraabdominal pressure on the mother’s 
already altered physiology were thought to pose more risk than benefits.  However, it 
has since been shown that the laparoscopic approach did not have additional risk and 
was superior to the open approach in terms of length of stay, diet advancement and 
duration of narcotic use.11 The first successful laparoscopic adrenalectomy in pregnancy 
was reported in 1999 and quickly became the preferred method of intervention.12 The 
use of the robot builds on the advantages of laparoscopy in pregnant patients by 
allowing for three-dimensional visualization, precise dissection and resection, and fine-
tuned articulations. The ergonomics of the technology, in the hands of a skilled robotic 
surgeon, make this ideal for manipulation around the gravid uterus. A recent meta-
analysis in non-pregnant patients compared robotic adrenalectomy to laparoscopic and 
demonstrated lower blood loss, shorter hospital stays, and no difference in conversion 
rates.13  Furthermore, Brunaud et al. demonstrated that, when controlling for learning 
curve of robotic usage, there was no significant difference in operation duration between 
the two approaches.14 In regard to the timing of surgery, second trimester intervention 
reduces risk of spontaneous abortion. Organogenesis is mostly complete by this time 





intervention.6  Potential disadvantages of the robotic approach include upfront costs of a 
robotic system, although with each subsequent use the cost of an individual procedure 
decreases.  Additionally, set up and footprint in the operating room can limit its practical 
use.  
A literature review showed two robotic adrenal surgeries in pregnancy in addition 
to this case.5,15 Podolsky et al. employed similar pregnancy-related robotic modifications 
while performing their right adrenalectomy indicated for pheochromocytoma. These 
included second trimester timing of surgery and maximum pneumoperitoneum of 12 
mmHg.  This latter modification limits deleterious effects on the fetus and mother, while 
still providing adequate visualization. Their case had an operative duration of 270 
minutes, estimated blood loss of 350 cc and the patient was discharged on POD 4. Key 
to proper management in Podolsky’s case, as well as ours, was the prompt 
determination of the functional status of the tumor along with perioperative care 
appropriate to the specific nature of the functional mass.  Additionally, they suggest 
continuous monitoring for acidosis and placing the patient in left lateral cubitus 
positioning to maximize maternal cardiac output and uterus and placental blood flow.15  
Nassi et al. also described a cortisol producing mass in their report, but their patient 
demonstrated physical symptoms of Cushing with moon facies, acne, hirsutism, and 
proximal muscle weakness. They also elaborated on the challenges of Cushing 
diagnosis in pregnancy, and ultimately decided to intervene in the second trimester due 
to fetal risks of adrenal pathology. Critical to the patient safety was the additional 
endocrine medical management of the patient with steroid replacement therapy 





described a healthy neonate that did not need glucocorticoid replacement during the 
neonatal period.5 These reported cases demonstrate the utility of robotic adrenalectomy 
in pregnancy, especially due to the maternal-fetal complications associated with 
untreated adrenal disease.  
Despite description of partial adrenalectomy in the literature,16,17 given that the 
patient was pregnant, it seemed prudent to perform a more definitive procedure to 
prevent extended operative time or reentry.  Additionally, the adenoma’s anatomy, 
which was central with involvement of a medial limb, made total adrenalectomy a more 
attractive approach.  However, since the procedure was successful, there is no clear 
contraindication to a partial adrenalectomy in this situation for future cases and 
amenable lesions.  
 
Conclusion: 
This case demonstrates the complexity of diagnosing adrenal adenomas in 
pregnancy, as physiologic hormonal changes can interfere with standard diagnostic 
testing. Robotic adrenalectomy should be considered as a feasible surgical treatment 
alternative in second trimester pregnant patients in the hands of a competent robotic 










Table 1 – Biochemical evaluation from initial hospital admission prior to pregnancy and 
preoperative testing during the second trimester. Values are plasma unless specified 
otherwise.   
PRA, plasma renin activity 
a Pregnancy test done prior to CT scan was negative 
b Repeat ACTH done at 2-week interval after initial measurement 
c ACTH values unchanged in pregnancy2 
 
Pre-pregnancy hospital admission testinga 
 First Hospital Admission Normal Range 
(non-pregnant) 
Aldosterone, ng/dL 3 <28 
PRA, ng/mL/h 0.08 0.9-28.9 
Aldosterone:PRA ratio 37.5 0.9-28.9 
















Testosterone, ng/dL 17 2-45 
Androstenedione, ng/dL 108 follicular phase: 35-250;  
luteal phase: 30-235 
DHEA, mcg/dL 43 45-430 
Potassium, mmol/L 2.9 3.3-4.8 












Aldosterone, ng/dL 13 6-104 9-104 15-101 
PRA, ng/mL/h 1.42  7.5-54.0 5.9-58.8 
ACTH, pg/mL <9 
<9b 
6 – 50c 6 - 50 6 - 50 






Figure 1 - CT scan identifying 4.2 cm right adrenal incidentaloma with heterogeneously 







Figure 2 - A. Gravid uterus identified during port placement B. Adrenal Mass identified 
with isolation of the adrenal vein C. Adrenal fossa after resection showing clipped 







Figure 3 - A. Tumor surrounded by thin capsule, with a rim of residual normal adrenal 
tissue, 40x magnification. B. Tumor cells, 100x magnification. C. Focus of infarct 
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